Dana-Farber Brigham Cancer Center

Running trials

• Active, not recruiting

  Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

  NCT05555732· Phase 3· Source

• Active, not recruiting

  DARA RVD For High Risk SMM

  NCT04775550· Phase 2· Source

• Active, not recruiting

  Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia

  NCT00003861· Source

• Active, not recruiting

  Cytogenetic Studies in Acute Leukemia and Multiple Myeloma

  NCT00048958· Source

Researchers

• SSSarah Sammons

Trial sites

• Dana-Farber/Brigham and Women's Cancer Center2 trials
• Dana Farber Brigham Cancer Center1 trial
• Dana-Farber Brigham Cancer Center1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Prostate cancer52 works · 0 trials
• Metastatic breast cancer15 works · 0 trials